EnChroma, Inc.

Berkeley, CA · Founded 2010 · Medtech · Private

Optical glasses that correct color vision deficiency by filtering and redirecting specific wavelengths of light

Claim this profile

Follows are private to you and power your alerts

Updated · enchroma.com

Sector
Medtech
Headquarters
Berkeley, CA
Founded
2010
Latest Form D
$200K, Jun 2012
Total capital
$1M
Federal grants
$275K
1 award · 2024
At sector median 1 award
Private capital raised
$730K
3 Form D · last Jun 2012
172 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
11
15 pending · first 2019
Rank in peer group#190 of 1112

Capital timeline

2011201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $1M$275K3rd Form D$200K
2011201520192023FEDERAL ↑EQUITY ↓Cumulative $1M$275K3rd Form D$200K

Latest events

  • Federal grantNSF · Phase I · SBIR Phase I: Contact lens for assisting color vision deficiency$275K
  • Private capital raisedForm D · SEC · 3rd filing$200K
  • Private capital raisedForm D · SEC · 2nd filing$430K
  • Private capital raisedForm D · SEC · 1st filing$100K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#190 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Andrew Water SchmederResearcherExecutive Officer, DirectorLinked by 9 patents
  • Donald Paul McPhersonResearcherExecutive Officer, DirectorLinked by 1 patent · $275K in grants as PI
  • Andrew 94609 ShmederExecutive Officer, DirectorNamed in SEC Form D filings
  • Anthony Paul DykesExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 11 granted of 26
Show all 26 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .